More information available to psoriasis patients in new label update
Last updated: 01 November 2019
You can legally access new medicines, even if they are not approved in your country.
Learn more »
A new package insert, approved by the FDA, includes information about psoriasis in the genital area.
This new development may increase chances of patients discussing the disease with their doctor — and healthcare professionals being better poised to treat it.
You can read about the study that prompted the update and why it’s important in this Drugs.com article.
